The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 29, No. 2, pp. 187-188.
© 1995 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seyss, C
Right arrow Articles by Foote, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seyss, C
Right arrow Articles by Foote, E.

Research Articles

Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity

C Seyss and EF Foote

Because of both an absence of sufficient data and the concern for increased toxicity in certain patient populations, the use of CCBs to reduce radiocontrast-associated nephrotoxicity is not recommended. Additional prospective, randomized trials are needed.


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
M. A. Stevens, P. A. McCullough, K. J. Tobin, J. P. Speck, D. C. Westveer, D. A. Guido-Allen, G. C. Timmis, and W. W. O'Neill
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. study
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 403 - 411.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1995 by Harvey Whitney Books Company.